Frontiers of COVID-19
Description
This book aims to serve the critical interests of the global community by supplying the most current knowledge and understanding of Covid-19 epidemiology, treatment, and prognoses. There was much uncertain and contradictory information published in the first year of the novel coronavirus. The dynamics of COVID-19 have now been realized, including the type of antibodies produced in infected patients and their limited lasting endurance. This book will set the record straight on the concept of "herd immunity" and explore the current vaccine trials taking place in different countries. This comprehensive book will illuminate recent advances regarding COVID-19 and offer a possible roadmap on how to move forward.
Frontiers of COVID-19: A Pathophysiology and Epidemiology Roadmap of Novel Coronavirus Disease will be a vital and forward-looking guide for infectious disease clinicians, scientists and researchers, and students at the graduate level.
More details
Other editions
Additional editions
Persons
Sasan Adibi, PhD, Senior Member, IEEE
School of IT
Deakin University
Melbourne, Australia
A/Prof Paul Griffin
B.Sc. (Hons), MBBS, FRACP, FRCPA, FACTM
School of Medicine, University of Queensland, Queensland, Australia
Department of Infectious Diseases, Mater Health, Queensland, Australia
Melvin Sanicas, MD, MSc, FRSPH, FRSA
Senior Medical Director, Global Medical Affairs
Clover Biopharmaceuticals
Zurich, Switzerland
Maryam Rashidi, MD, PhD
Senior Postdoctoral Researcher
Immunology and Inflammation
Walter & Eliza Hall Institute of Medical Research (WEHI)
Melbourne, Australia
Francesco Lanfranchi, MD
Nuclear Medicine Unit
Department of Health Sciences (DISSAL)University of Genoa
Genoa, Italy